154 related articles for article (PubMed ID: 30165098)
21. Sequential intravenous injection of anionic polymer and cationic lipoplex of siRNA could effectively deliver siRNA to the liver.
Hattori Y; Arai S; Okamoto R; Hamada M; Kawano K; Yonemochi E
Int J Pharm; 2014 Dec; 476(1-2):289-98. PubMed ID: 25290812
[TBL] [Abstract][Full Text] [Related]
22. TNFα siRNA delivery by nanoparticles and photochemical internalization for psoriasis topical therapy.
Suzuki IL; de Araujo MM; Bagnato VS; Bentley MVLB
J Control Release; 2021 Oct; 338():316-329. PubMed ID: 34437914
[TBL] [Abstract][Full Text] [Related]
23. Effective Skin Cancer Treatment by Topical Co-delivery of Curcumin and STAT3 siRNA Using Cationic Liposomes.
Jose A; Labala S; Ninave KM; Gade SK; Venuganti VVK
AAPS PharmSciTech; 2018 Jan; 19(1):166-175. PubMed ID: 28639178
[TBL] [Abstract][Full Text] [Related]
24. Skin-penetrating polymeric nanoparticles incorporated in silk fibroin hydrogel for topical delivery of curcumin to improve its therapeutic effect on psoriasis mouse model.
Mao KL; Fan ZL; Yuan JD; Chen PP; Yang JJ; Xu J; ZhuGe DL; Jin BH; Zhu QY; Shen BX; Sohawon Y; Zhao YZ; Xu HL
Colloids Surf B Biointerfaces; 2017 Dec; 160():704-714. PubMed ID: 29035818
[TBL] [Abstract][Full Text] [Related]
25. Using siRNA-based spherical nucleic acid nanoparticle conjugates for gene regulation in psoriasis.
Nemati H; Ghahramani MH; Faridi-Majidi R; Izadi B; Bahrami G; Madani SH; Tavoosidana G
J Control Release; 2017 Dec; 268():259-268. PubMed ID: 29074408
[TBL] [Abstract][Full Text] [Related]
26. The co-delivery of oxaliplatin abrogates the immunogenic response to PEGylated siRNA-lipoplex.
Alaaeldin E; Abu Lila AS; Moriyoshi N; Sarhan HA; Ishida T; Khaled KA; Kiwada H
Pharm Res; 2013 Sep; 30(9):2344-54. PubMed ID: 23673556
[TBL] [Abstract][Full Text] [Related]
27. An Anti-Inflammatory Poly(PhosphorHydrazone) Dendrimer Capped with AzaBisPhosphonate Groups to Treat Psoriasis.
Jebbawi R; Oukhrib A; Clement E; Blanzat M; Turrin CO; Caminade AM; Lacoste E; Fruchon S; Poupot R
Biomolecules; 2020 Jun; 10(6):. PubMed ID: 32586038
[TBL] [Abstract][Full Text] [Related]
28. DOTAP functionalizing single-walled carbon nanotubes as non-viral vectors for efficient intracellular siRNA delivery.
Li H; Hao Y; Wang N; Wang L; Jia S; Wang Y; Yang L; Zhang Y; Zhang Z
Drug Deliv; 2016; 23(3):840-8. PubMed ID: 24892622
[TBL] [Abstract][Full Text] [Related]
29. Toxicological exploration of peptide-based cationic liposomes in siRNA delivery.
Zhu Y; Meng Y; Zhao Y; Zhu J; Xu H; Zhang E; Shi L; Du L; Liu G; Zhang C; Xu X; Kang X; Zhen Y; Zhang S
Colloids Surf B Biointerfaces; 2019 Jul; 179():66-76. PubMed ID: 30947085
[TBL] [Abstract][Full Text] [Related]
30. One-step encapsulation of siRNA between lipid-layers of multi-layer polycation liposomes by lipoplex freeze-thawing.
Koide H; Okamoto A; Tsuchida H; Ando H; Ariizumi S; Kiyokawa C; Hashimoto M; Asai T; Dewa T; Oku N
J Control Release; 2016 Apr; 228():1-8. PubMed ID: 26826309
[TBL] [Abstract][Full Text] [Related]
31. Development of edge-activated liposomes for siRNA delivery to human basal epidermis for melanoma therapy.
Dorrani M; Garbuzenko OB; Minko T; Michniak-Kohn B
J Control Release; 2016 Apr; 228():150-158. PubMed ID: 26965957
[TBL] [Abstract][Full Text] [Related]
32. Design of an inhalable dry powder formulation of DOTAP-modified PLGA nanoparticles loaded with siRNA.
Jensen DK; Jensen LB; Koocheki S; Bengtson L; Cun D; Nielsen HM; Foged C
J Control Release; 2012 Jan; 157(1):141-8. PubMed ID: 21864597
[TBL] [Abstract][Full Text] [Related]
33. Poly (amidoamine) (PAMAM) dendrimer mediated delivery of drug and pDNA/siRNA for cancer therapy.
Li J; Liang H; Liu J; Wang Z
Int J Pharm; 2018 Jul; 546(1-2):215-225. PubMed ID: 29787895
[TBL] [Abstract][Full Text] [Related]
34. Paeoniflorin inhibits skin lesions in imiquimod-induced psoriasis-like mice by downregulating inflammation.
Sun Y; Zhang J; Huo R; Zhai T; Li H; Wu P; Zhu X; Zhou Z; Shen B; Li N
Int Immunopharmacol; 2015 Feb; 24(2):392-399. PubMed ID: 25576402
[TBL] [Abstract][Full Text] [Related]
35. Efficient siRNA delivery using novel siRNA-loaded Bubble liposomes and ultrasound.
Endo-Takahashi Y; Negishi Y; Kato Y; Suzuki R; Maruyama K; Aramaki Y
Int J Pharm; 2012 Jan; 422(1-2):504-9. PubMed ID: 22119963
[TBL] [Abstract][Full Text] [Related]
36. Effect of "helper lipid" on lipoplex electrostatics.
Hirsch-Lerner D; Zhang M; Eliyahu H; Ferrari ME; Wheeler CJ; Barenholz Y
Biochim Biophys Acta; 2005 Aug; 1714(2):71-84. PubMed ID: 16051183
[TBL] [Abstract][Full Text] [Related]
37. In vivo delivery of siRNA to the brain by carbosilane dendrimer.
Serramía MJ; Álvarez S; Fuentes-Paniagua E; Clemente MI; Sánchez-Nieves J; Gómez R; de la Mata J; Muñoz-Fernández MÁ
J Control Release; 2015 Feb; 200():60-70. PubMed ID: 25559178
[TBL] [Abstract][Full Text] [Related]
38. Potential use of glucuronylglucosyl-β-cyclodextrin/dendrimer conjugate (G2) as a siRNA carrier for the treatment of familial amyloidotic polyneuropathy.
Anno T; Higashi T; Hayashi Y; Motoyama K; Jono H; Ando Y; Arima H
J Drug Target; 2014 Dec; 22(10):883-90. PubMed ID: 25051178
[TBL] [Abstract][Full Text] [Related]
39. Enhanced siRNA delivery using cationic liposomes with new polyarginine-conjugated PEG-lipid.
Kim HK; Davaa E; Myung CS; Park JS
Int J Pharm; 2010 Jun; 392(1-2):141-7. PubMed ID: 20347025
[TBL] [Abstract][Full Text] [Related]
40. CXCL1 gene silencing in skin using liposome-encapsulated siRNA delivered by microprojection array.
Haigh O; Depelsenaire AC; Meliga SC; Yukiko SR; McMillan NA; Frazer IH; Kendall MA
J Control Release; 2014 Nov; 194():148-56. PubMed ID: 25192942
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
